Alloy Review: What You Actually Get
A menopause-specialised telehealth service that also prescribes GLP-1s — a combination that matters clinically for midlife women, though it publishes no pricing at all.
How we're paid: Some links on this site are affiliate links, and we earn a commission when readers sign up through them. Every figure below was taken from Alloy's own published pages on the date shown, and is listed with its source at the bottom of this review. Full disclosure →
Overview
Alloy is built around menopause care, and the GLP-1 offering sits inside that specialisation rather than beside it. That framing is the reason to consider it: weight change during perimenopause and menopause involves hormonal shifts that a general weight-loss platform is not set up to think about, and a service treating both in one place can at least see the whole picture.
The medication lineup is broad for a specialist service. Brand-name Zepbound, Wegovy, and Foundayo — the oral GLP-1 approved in April 2026 — sit alongside compounded semaglutide, tirzepatide, and liraglutide. Alloy states HSA and FSA funds are eligible and describes itself as easy cash-pay with no insurance headaches.
The process is quick: a 5-10 minute intake, a physician-generated treatment plan in under 12 hours, and 24/7 messaging with your doctor thereafter. What Alloy does not publish is any price, any eligibility criteria, or whether the weight-loss service is restricted to menopause-related use. Notably, the page emphasises menopause-specialised care but does not explicitly limit GLP-1 prescribing to that context.
Medications Offered
Brand-name (FDA-approved)
- •Zepbound (tirzepatide)
- •Wegovy (semaglutide)
- •Foundayo (orforglipron) — daily oral tablet
Compounded
- •Compounded semaglutide
- •Compounded tirzepatide
- •Compounded liraglutide
A wide formulary for a specialist service, covering both manufacturers' brand-name products and three compounded molecules. Alloy is one of relatively few providers to list Foundayo already, and one of few to offer compounded liraglutide. Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality.
How the Program Works
Consultation process
A 5-10 minute intake form, after which a physician generates a treatment plan in under 12 hours. Ongoing support is described as 24/7 messaging with your doctor. No video visit is described on the pages we reviewed.
Eligibility
Not published. Alloy is a menopause-focused platform, but the pages we reviewed do not state age requirements, menopause status requirements, BMI thresholds, or exclusions — nor do they explicitly restrict weight-loss medication to menopause-related use.
Provider involvement
A physician generates your treatment plan, and 24/7 messaging with a doctor is described as an ongoing support feature. Specific clinician credentials are not published.
Lab requirements
Not stated on the pages we reviewed.
Pharmacy fulfillment
Not named on the pages we reviewed.
Shipping
Not stated on the pages we reviewed.
Support services
24/7 doctor messaging, within a service specialising in menopause care. That specialisation is the substantive support difference rather than a coaching program.
Insurance
Alloy describes an "easy cash-pay, no insurance headaches" model. No insurance billing or benefits assistance is described.
Pricing
Membership fee
Not published on the pages we reviewed.
| Medication / plan | Published price | Notes |
|---|---|---|
| Membership or program fee | Not published | No figure stated |
| Compounded GLP-1s | Not published | Semaglutide, tirzepatide, liraglutide offered |
| Brand-name GLP-1s | Not published | Zepbound, Wegovy, Foundayo listed |
| Payment method | HSA/FSA eligible | Cash-pay model |
Prices as published by Alloy on August 5, 2026. Telehealth pricing changes often, and promotional first-month rates are common. Check the provider's own page before you commit. We could not verify any price for this review.
Cancellation, Refunds & Payment
Cancellation policy
Not stated on the pages we reviewed.
Refund policy
Not stated on the pages we reviewed.
HSA / FSA
Alloy states the service is HSA and FSA eligible — one of only a handful of providers in our review set to address this explicitly.
Insurance handling
Alloy describes an "easy cash-pay, no insurance headaches" model. No insurance billing or benefits assistance is described.
What We Like
Menopause specialisation is a genuine clinical difference
Weight change in midlife is entangled with hormonal change, and a service that treats both can consider them together. For women navigating perimenopause alongside weight management, a general GLP-1 platform simply is not looking at the same picture.
A wide formulary for a specialist service
Zepbound, Wegovy, and Foundayo on the brand side, with compounded semaglutide, tirzepatide, and liraglutide. Compounded liraglutide in particular is rare, and Foundayo is newer than many competitors' catalogues.
Explicit HSA/FSA eligibility
Stated plainly, which almost nobody else does. Using pre-tax dollars is effectively a 20-35% discount depending on your bracket.
Fast turnaround with real ongoing access
A physician-generated plan in under 12 hours and 24/7 doctor messaging is quick without dispensing with the clinical relationship afterward.
What We'd Improve
No published pricing whatsoever
Not a program fee, not a medication price, not a range. Alloy is one of several providers we reviewed that publishes nothing on cost, and it makes comparison impossible.
No published eligibility criteria
No BMI thresholds, no exclusions, and no statement of whether the GLP-1 service requires menopause-related indication. For a specialist platform, clarifying who the service is actually for would be straightforward.
The specialisation boundary is ambiguous
The pages emphasise menopause care but do not restrict weight-loss prescribing to it. Prospective patients cannot tell whether they are getting menopause-informed weight care or a general GLP-1 service with menopause branding.
Nothing on labs, pharmacies, shipping, cancellation, or refunds
Given that hormone-related care usually involves lab work, the silence on lab requirements is a particularly odd omission here.
Who It May Be Best For
Worth considering if you:
- •Are navigating perimenopause or menopause alongside weight management
- •Want hormonal and metabolic care considered together rather than separately
- •Want to pay with HSA or FSA funds and need that confirmed
- •Value fast turnaround with 24/7 physician messaging
- •Are interested in Foundayo or compounded liraglutide
Probably not if you:
- •Need to know what anything costs before enrolling
- •Want published eligibility criteria
- •Are relying on insurance coverage
- •Want lab work as a defined part of the program
- •Are not in the population Alloy is built around
Limitations of This Review
- •Alloy publishes no pricing on the pages we reviewed, so the cost section of this review is necessarily empty. That reflects their disclosure, not our effort.
- •We reviewed published pages rather than enrolling, so we cannot assess clinician quality, the depth of the menopause specialisation in practice, or fulfilment.
- •Eligibility criteria, lab requirements, pharmacy partners, shipping, cancellation, and refund terms are all unpublished.
- •We take no position on whether menopause-specialised care produces better weight outcomes. That question has not been settled for any specific commercial program, and our credit here is for the clinical framing rather than for demonstrated results.
Alternatives
Form Health
The other clinically specialised option — board-certified obesity medicine physicians — though it also publishes no pricing.
Mochi Health
General weight care, but with both membership and medication prices published and dietitians included.
Eden
Also accepts HSA/FSA cards and offers hormone therapies alongside GLP-1s.
PlushCare
A primary-care relationship covering more than weight, with published pricing and eligibility criteria.
Our Verdict
Alloy is the only provider in our review set treating weight management as part of midlife hormonal health rather than as a standalone problem, and that framing is genuinely worth something. For a woman navigating perimenopause who is also being told to lose weight, being able to discuss both with the same clinician is a real advantage over a platform that only knows about appetite.
The formulary supports that seriousness — Zepbound, Wegovy, and Foundayo on the brand side, with three compounded molecules including liraglutide. Explicit HSA/FSA eligibility is a further practical plus that most competitors leave unsaid.
What we cannot do is tell you what it costs, whether you qualify, or whether the weight service is actually restricted to its stated population. Alloy publishes none of it. For a company whose whole proposition is specialised care for a specific group, not defining that group in writing is a strange gap.
Worth considering if you are in the population Alloy is built for and are willing to establish the basics by asking. If you want a knowable price or a general weight-management service, providers that publish both are easy to find.
Frequently Asked Questions
How much does Alloy cost?+
Alloy does not publish pricing on the pages we reviewed — no program fee, no medication prices, no range. It describes an easy cash-pay model and states the service is HSA and FSA eligible, but you will need to enter the signup flow or contact them to learn what you would pay.
Do I have to be in menopause to use Alloy for weight loss?+
Not stated. Alloy is a menopause-specialised platform and the pages emphasise that focus, but they do not explicitly restrict weight-loss medication to menopause-related use. If you are outside that population, ask before investing time in an intake.
Why does menopause specialisation matter for weight?+
Weight change during perimenopause and menopause is bound up with hormonal change, shifts in body composition, and sleep disruption. A service treating hormonal and metabolic health together can consider those interactions, where a general weight-loss platform is not set up to. That is a reasonable clinical rationale — though no specific commercial program has demonstrated better outcomes because of it.
Does Alloy offer Foundayo?+
Yes. Foundayo (orforglipron), the oral GLP-1 approved in April 2026, appears in Alloy's lineup alongside Zepbound and Wegovy. The price is not published.
Can I use HSA or FSA funds?+
Alloy states the service is HSA and FSA eligible. Because those contributions are pre-tax, that is effectively a discount at your marginal rate. Confirm specifics with your plan administrator.
Does Alloy take insurance?+
No. Alloy describes an "easy cash-pay, no insurance headaches" model. If insurance coverage is your priority, Found and PlushCare are built around it.
Where These Facts Came From
Every price, medication, and policy above was read directly from these pages on August 5, 2026. Where a provider does not publish something, we say so rather than estimate it.
Compare This Against Every Other Provider
Side-by-side pricing, medication access, and support for the platforms we've reviewed.
Compare All Providers🇺🇸Medical Disclaimer
Your health, your doctor. This review is information, not medical advice. We're researchers and reviewers, not clinicians. GLP-1 medications are prescription drugs that require physician oversight, and they aren't appropriate for everyone. Talk to your healthcare provider about whether this class of medication fits your health situation. Individual responses vary significantly. Reviewed August 5, 2026.